Together with a group of international experts from different perspectives of drug development, Chinese Clinical Oncology has launched a special issue on The Changing World of Drug Development in June 2014. The Guest Editor Dr. Christian Dittrich Professor of Medicine, Center for Oncology and Hematology, serves in European Organisation for Research and Treatment of Cancer (EORTC)-New Drug Advisory Committee (NDAC).
Cancer drug development is undergoing a substantial shift nowadays. The underlying drivers are multi-factorial. This special issue has illustrated the respective role of patients, laboratory, clinical trials, drug companies, regulatory bodies, and also the economic principle in drug development, aiming at facilitating drug research in the near future.